Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Apr;84(4):337-9.
doi: 10.1136/adc.84.4.337.

A novel scheme for the reporting of adverse drug reactions

A Clarkson  1 , E Ingleby, I Choonara, P Bryan, P Arlett
Affiliations

A novel scheme for the reporting of adverse drug reactions

A Clarkson et al. Arch Dis Child. 2001 Apr.

Abstract

Background: The safety of medicines used in children is of considerable public interest, yet available data to monitor the safety of medicines in children is limited.

Aims: To raise awareness and stimulate reporting of adverse drug reactions (ADRs) in children in the Trent region.

Methods: A pilot Paediatric Regional Monitoring Centre (PRMC) has been established in the Trent region. The scheme operates as an extension of the UK's spontaneous reporting scheme, the Yellow Card Scheme run by the Medicines Control Agency and the Committee on Safety of Medicines. Proactive interventions including a monthly reminder letter and presentations to staff in the identified hospitals have been made.

Results: During the first year of the PRMC, 95 reports were received from the Trent region compared to 40 for the previous year. Twenty four of these reports were for medicines used "off label". The 95 reports involved 105 drugs and 171 suspected ADRs. Twenty six of the ADRs (15%) were considered medically significant.

Conclusions: The number of ADR reports from the Trent region has increased considerably in the first year of the scheme. The results show that intensive education and promotion of ADR reporting can result in a major increase in reporting. This initiative will increase our knowledge about the safety of medicines used to treat children and so help protect public health.

PubMed Disclaimer

References

    1. BMJ. 2000 Jan 8;320(7227):79-82 - PubMed
    1. Prof Nurse. 2000 Feb;15(5):300-4 - PubMed
    1. BMJ. 1998 Jan 31;316(7128):343-5 - PubMed
    1. Adverse Drug React Acute Poisoning Rev. 1990 Summer;9(2):103-18 - PubMed
    1. Br J Clin Pharmacol. 1996 Oct;42(4):407-10 - PubMed

Publication types